Otsuka Holdings CoSTU:OS1 +2.56%86 PB Ratio is 1.87 as of Jun. 26, 2026, which is 34% above its 10-year median of 1.40. GuruFocus rates STU:OS1 with a GF Score™ of 86/100 and a GF Value™ of €45.23 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 922 Drug Manufacturers companies, Otsuka Holdings Co ranks better than 50.33% on this metric.
The historical rank and industry rank for Otsuka Holdings Co's PB Ratio or its related term are showing as below:
STU:OS1'
s PB Ratio Range Over the Past 10 Years
Min: 0.96 Med: 1.4 Max: 2.05
Current: 1.83
During the past 13 years, Otsuka Holdings Co's highest PB Ratio was 2.05. The lowest was 0.96. And the median was 1.40.
STU:OS1's PB Ratio is ranked better than 50.33% of 922
companies
in the Drug Manufacturers industry
Industry Median: 1.855
vs STU:OS1: 1.83
During the past 12 months, Otsuka Holdings Co's average Book Value Per Share Growth Rate was 17.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 11.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 10.90% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 6.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Otsuka Holdings Co was 13.10% per year. The lowest was 0.10% per year. And the median was 8.25% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Otsuka Holdings Co PB Ratio Related Terms
Otsuka Holdings Co PB Ratio Historical Data
* Premium members only.
The historical data trend for Otsuka Holdings Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Otsuka Holdings Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Otsuka Holdings Co PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Otsuka Holdings Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Otsuka Holdings Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Otsuka Holdings Co (STU:OS1) has a PB Ratio of 1.87 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Otsuka Holdings Co and its competitors. This is 34% above median its historical median of 1.40. Over the past decade, Otsuka Holdings Co's PB Ratio has ranged from 0.96 to 2.05. According to the industry distribution chart, Otsuka Holdings Co ranks #458 out of 922 companies in the Drug Manufacturers industry, placing it in the top 49.7%.
Is Otsuka Holdings Co's PB Ratio too high?
Otsuka Holdings Co's current PB Ratio of 1.87 is 34% above median its 10-year median of 1.40. Over the past 10 years, this metric has ranged from a low of 0.96 to a high of 2.05. The Drug Manufacturers industry median PB Ratio is 1.86. Otsuka Holdings Co's value of 1.87 is 0.8% above this industry median. Based on the distribution chart, Otsuka Holdings Co ranks #458 out of 922 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Otsuka Holdings Co has a GF Score™ of 86/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Otsuka Holdings Co's PB Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Otsuka Holdings Co ranks #458 out of 922 companies for PB Ratio. This puts Otsuka Holdings Co in the upper half of its industry. The industry median PB Ratio is 1.86. Otsuka Holdings Co's value of 1.87 is 0.8% above this benchmark. Historically, Otsuka Holdings Co's own PB Ratio has ranged from 0.96 to 2.05 over the past decade. While the company's 10-year median is 1.40 vs. the industry median of 1.86, Otsuka Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.86, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Otsuka Holdings Co's current PB Ratio of 1.87 is 0.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Otsuka Holdings Co and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Otsuka Holdings Co's current PB Ratio is 1.87, which is 34% above median its own 10-year median of 1.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otsuka Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Otsuka Holdings Co (STU:OS1) is currently considered Significantly Overvalued. The stock's GF Value™ is €45.23, compared to a current price of €60.00 — trading 32.7% above its estimated fair value. The current PB Ratio is 1.87, which is 34% above median its 10-year median of 1.40 and 0.8% above the Drug Manufacturers industry median of 1.86. Otsuka Holdings Co's overall GF Score™ is 86/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Otsuka Holdings Co (STU:OS1), the current PB Ratio is 1.87 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Otsuka Holdings Co (STU:OS1) Overvalued in 2026?
Based on GuruFocus' analysis, Otsuka Holdings Co stock appears to be overvalued.
The current stock price of €60.00 is trading 32.7% above its estimated GF Value™ of €45.23.
GuruFocus considers Otsuka Holdings Co to be Significantly Overvalued.
Key valuation signals for STU:OS1:
PB Ratio: 1.87 (34% above median its 10-year median of 1.40)
GF Value™: €45.23 vs. price of €60.00 (32.7% above fair value)
Industry Position: 0.8% above the Drug Manufacturers median (#458 of 922)
No single metric tells the full story. See the STU:OS1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Otsuka Holdings Co Ltd is a Japan-based company that operates in pharmaceuticals, nutraceuticals, and consumer products. It operates through four reportable segments: Medical-related Business, Nutraceutical-related Business, Consumer-related Business, and Other Business. The Medical Business manufactures and sells therapeutic drugs and infusions, the Nutraceutical Business produces functional foods, beverages, and nutritional supplements, the Consumer Business offers mineral water, beverages, and foods, while the Other Business provides storage services and manufactures chemicals and analytical equipment. It generates the majority of its revenue from the medical-related business segment.
86GF Score
Get the complete analysis for STU:OS1
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:OS1 has been successfully added to your 
